2020
DOI: 10.1016/j.oooo.2019.09.017
|View full text |Cite
|
Sign up to set email alerts
|

Unusual intraoral cancer with unexpected outcome in a patient with xeroderma pigmentosum: An alert for antineoplastic treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 79 publications
0
11
0
Order By: Relevance
“…13,15 Depending on the degree of XP-C inactivity and the damage caused to normal cells, cisplatin can be fatal, especially as a result of renal failure as the kidneys are the principle route of drug elimination. 6,13 Due to the lack of evidence supporting the use of cisplatin in cutaneous SCC and the concerns related to efficacy and toxicity in patients with XP, other treatment options should be explored. A patient with XP and a skin SCC was initially treated with cisplatin and infusional fluorouracil.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…13,15 Depending on the degree of XP-C inactivity and the damage caused to normal cells, cisplatin can be fatal, especially as a result of renal failure as the kidneys are the principle route of drug elimination. 6,13 Due to the lack of evidence supporting the use of cisplatin in cutaneous SCC and the concerns related to efficacy and toxicity in patients with XP, other treatment options should be explored. A patient with XP and a skin SCC was initially treated with cisplatin and infusional fluorouracil.…”
Section: Discussionmentioning
confidence: 99%
“…13 In patients with XP, who are potential carriers of defective XP-C, this mechanism, designed to reverse the damage caused by cisplatin chemotherapy in normal cells, can be compromised, resulting in normal cells also undergoing apoptosis. 13,15 Depending on the degree of XP-C inactivity and the damage caused to normal cells, cisplatin can be fatal, especially as a result of renal failure as the kidneys are the principle route of drug elimination. 6,13 Due to the lack of evidence supporting the use of cisplatin in cutaneous SCC and the concerns related to efficacy and toxicity in patients with XP, other treatment options should be explored.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations